US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 1.623
  • -0.037-2.22%
Trading Nov 15 11:30 ET
42.69MMarket Cap-1823P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LAVA Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--

Unlock Free Earnings Estimates

LAVA Therapeutics Earnings Reports

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 21 04:03

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 22 04:10

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 21 19:06

  • LAVA Therapeutics | 20-F: FY2023 Annual Report

    Mar 21 04:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 28, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data